Clinical Trial Update: Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

View source ↗

Summary

A clinical trial evaluating the combination of Yttrium-90 microsphere radioembolization with FOLFIRI and bevacizumab for second-line treatment of metastatic col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Yttrium-90 microsphere therapy (Yttrium-90 microspheres)

Snippet

Sponsor: Zhongda Hospital | Conditions: Colorectal Cancer Metastatic | Status: RECRUITING